{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:37:24Z","timestamp":1784824644285,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40291-022-00603-4","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T10:02:53Z","timestamp":1657015373000},"page":"541-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-8614","authenticated-orcid":false,"given":"Shin-Shin","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1474","authenticated-orcid":false,"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"issue":"3","key":"603_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","volume":"50","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):377\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"603_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509.","journal-title":"N Engl J Med"},{"issue":"9583","key":"603_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet"},{"issue":"11","key":"603_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","author":"A Strange","year":"2010","unstructured":"Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42(11):985\u201390.","journal-title":"Nat Genet"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"15382","DOI":"10.1038\/ncomms15382","volume":"8","author":"LC Tsoi","year":"2017","unstructured":"Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382.","journal-title":"Nat Commun"},{"issue":"9","key":"603_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.autrev.2017.07.011","volume":"16","author":"JC Prinz","year":"2017","unstructured":"Prinz JC. Autoimmune aspects of psoriasis: Heritability and autoantigens. Autoimmun Rev. 2017;16(9):970\u20139.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"603_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","volume":"178","author":"L Chen","year":"2018","unstructured":"Chen L, Tsai TF. HLA-Cw6 and psoriasis. Br J Dermatol. 2018;178(4):854\u201362.","journal-title":"Br J Dermatol"},{"issue":"3","key":"603_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.1365-2133.2003.05166.x","volume":"148","author":"YT Chang","year":"2003","unstructured":"Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, et al. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br J Dermatol. 2003;148(3):418\u201323.","journal-title":"Br J Dermatol"},{"issue":"2","key":"603_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","volume":"102","author":"A Tiilikainen","year":"1980","unstructured":"Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M. Psoriasis and HLA-Cw6. Br J Dermatol. 1980;102(2):179\u201384.","journal-title":"Br J Dermatol"},{"issue":"2","key":"603_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2133.2011.10688.x","volume":"166","author":"HY Chiu","year":"2012","unstructured":"Chiu HY, Huang PY, Jee SH, Hu CY, Chou CT, Chang YT, et al. HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis. Br J Dermatol. 2012;166(2):288\u201397.","journal-title":"Br J Dermatol"},{"issue":"3","key":"603_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40257-020-00585-1","volume":"22","author":"YW Huang","year":"2021","unstructured":"Huang YW, Tsai TF. HLA-Cw1 and psoriasis. Am J Clin Dermatol. 2021;22(3):339\u201347.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"603_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1046\/j.1365-4362.2002.01496.x","volume":"41","author":"C Choonhakarn","year":"2002","unstructured":"Choonhakarn C, Romphruk A, Puapairoj C, Jirarattanapochai K, Romphruk A, Leelayuwat C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int J Dermatol. 2002;41(6):330\u20134.","journal-title":"Int J Dermatol"},{"issue":"1","key":"603_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40291-019-00441-x","volume":"24","author":"Y Lo","year":"2020","unstructured":"Lo Y, Chiu HY, Tsai TF. Clinical features and genetic polymorphism in Chinese patients with erythrodermic psoriasis in a single dermatologic clinic. Mol Diagn Ther. 2020;24(1):85\u201393.","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"603_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1346-8138.1998.tb02461.x","volume":"25","author":"A Ozawa","year":"1998","unstructured":"Ozawa A, Miyahara M, Sugai J, Iizuka M, Kawakubo Y, Matsuo I, et al. HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303. J Dermatol. 1998;25(9):573\u201381.","journal-title":"J Dermatol"},{"issue":"1","key":"603_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11\u201327.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"603_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjd.12425","volume":"169","author":"E Gallo","year":"2013","unstructured":"Gallo E, Cabaleiro T, Rom\u00e1n M, Solano-L\u00f3pez G, Abad-Santos F, Garc\u00eda-D\u00edez A, et al. The relationship between tumour necrosis factor (TNF)-\u03b1 promoter and IL12B\/IL-23R genes polymorphisms and the efficacy of anti-TNF-\u03b1 therapy in psoriasis: a case-control study. Br J Dermatol. 2013;169(4):819\u201329.","journal-title":"Br J Dermatol"},{"issue":"12","key":"603_CR17","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.jid.2016.06.631","volume":"136","author":"K Li","year":"2016","unstructured":"Li K, Huang CC, Randazzo B, Li S, Szapary P, Curran M, et al. HLA-C*06:02 allele and response to IL-12\/23 inhibition: Results from the ustekinumab phase 3 psoriasis program. J Investig Dermatol. 2016;136(12):2364\u201371.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"603_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/bjd.12331","volume":"169","author":"M Talamonti","year":"2013","unstructured":"Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, et al. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B\/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12\/23 blocker ustekinumab. Br J Dermatol. 2013;169(2):458\u201363.","journal-title":"Br J Dermatol"},{"issue":"12","key":"603_CR19","doi-asserted-by":"publisher","first-page":"e898","DOI":"10.1111\/jdv.17544","volume":"35","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ding X, Meng Z, Chen M, Zheng X, Cai M, et al. A Genome-wide association study identified HLA-C associated with the effectiveness of methotrexate for psoriasis treatment. J Eur Acad Dermatol Venereol. 2021;35(12):e898\u2013900.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"603_CR20","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","volume":"143","author":"N Dand","year":"2019","unstructured":"Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, et al. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J Allergy Clin Immunol. 2019;143(6):2120\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"603_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2133.2011.10712.x","volume":"166","author":"HL Hebert","year":"2012","unstructured":"Hebert HL, Ali FR, Bowes J, Griffiths CEM, Barton A, Warren RB. Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol. 2012;166(3):474\u201382.","journal-title":"Br J Dermatol"},{"issue":"3 Pt 1","key":"603_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/jid.2011.376","volume":"132","author":"T Tejasvi","year":"2012","unstructured":"Tejasvi T, Stuart PE, Chandran V, Voorhees JJ, Gladman DD, Rahman P, et al. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J Invest Dermatol. 2012;132(3 Pt 1):593\u2013600.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"603_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2340\/00015555-1440","volume":"93","author":"A Gedebjerg","year":"2013","unstructured":"Gedebjerg A, Johansen C, Kragballe K, Iversen L. IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab. Acta Derm Venereol. 2013;93(2):150\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"603_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40291-017-0274-z","volume":"21","author":"M Talamonti","year":"2017","unstructured":"Talamonti M, D\u2019Adamio S, Bianchi L, Galluzzo M. The role of pharmacogenetics in chronic plaque psoriasis: update of the literature. Mol Diagn Ther. 2017;21(5):467\u201380.","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"603_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/bjd.15005","volume":"176","author":"J van den Reek","year":"2017","unstructured":"van den Reek J, Coenen MJH, van de L\u2019Isle AM, Zweegers J, Rodijk-Olthuis D, Schalkwijk J, et al. Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis. Br J Dermatol. 2017;176(5):1288\u201396.","journal-title":"Br J Dermatol"},{"issue":"5","key":"603_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/bjd.13056","volume":"171","author":"HY Chiu","year":"2014","unstructured":"Chiu HY, Wang TS, Chan CC, Cheng YP, Lin SJ, Tsai TF. Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12\/23 blocker, in Chinese patients with psoriasis: a retrospective analysis. Br J Dermatol. 2014;171(5):1181\u20138.","journal-title":"Br J Dermatol"},{"issue":"2","key":"603_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jaad.2015.08.055","volume":"74","author":"M Talamonti","year":"2016","unstructured":"Talamonti M, Galluzzo M, Chimenti S, Costanzo A. HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: outcome and long-term follow-up. J Am Acad Dermatol. 2016;74(2):374\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"603_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/jid.2014.517","volume":"135","author":"PE Stuart","year":"2015","unstructured":"Stuart PE, Tejasvi T, Shaiq PA, Kullavanijaya P, Qamar R, Raja GK, et al. A single SNP surrogate for genotyping HLA-C*06:02 in diverse populations. J Invest Dermatol. 2015;135(4):1177\u201380.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"603_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00403-002-0324-0","volume":"294","author":"TF Tsai","year":"2002","unstructured":"Tsai TF, Hu CY, Tsai WL, Chu CY, Lin SJ, Liaw SH, et al. HLA-Cw6 specificity and polymorphic residues are associated with susceptibility among Chinese psoriatics in Taiwan. Arch Dermatol Res. 2002;294(5):214\u201320.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"603_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2340\/00015555-0253","volume":"87","author":"X Fan","year":"2007","unstructured":"Fan X, Yang S, Sun LD, Liang YH, Gao M, Zhang KY, et al. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol. 2007;87(4):335\u201340.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"603_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2133.1996.tb01497.x","volume":"135","author":"HF Gonzaga","year":"1996","unstructured":"Gonzaga HF, Torres EA, Alchorne MM, Gerbase-Delima M. Both psoriasis and benign migratory glossitis are associated with HLA-Cw6. Br J Dermatol. 1996;135(3):368\u201370.","journal-title":"Br J Dermatol"},{"issue":"4","key":"603_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1399-0039.2008.01096.x","volume":"72","author":"M Jobim","year":"2008","unstructured":"Jobim M, Jobim LF, Salim PH, Cestari TF, Toresan R, Gil BC, et al. A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris. Tissue Antigens. 2008;72(4):392\u20136.","journal-title":"Tissue Antigens"},{"issue":"5","key":"603_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.0022-202X.2005.23892.x","volume":"125","author":"J Mart\u0131nez-Borra","year":"2005","unstructured":"Mart\u0131nez-Borra J, Brautbar C, Gonzalez S, Enk CD, L\u00f3pez-V\u00e1zquez A, L\u00f3pez-Larrea C. The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population. J Invest Dermatol. 2005;125(5):928\u201332.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"603_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1399-0039.2010.01526.x","volume":"76","author":"PE Stuart","year":"2010","unstructured":"Stuart PE, Nair RP, Hiremagalore R, Kullavanijaya P, Kullavanijaya P, Tejasvi T, et al. Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1. Tissue Antigens. 2010;76(5):387\u201397.","journal-title":"Tissue Antigens"},{"issue":"9","key":"603_CR35","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.jid.2019.02.027","volume":"139","author":"M Cai","year":"2019","unstructured":"Cai M, Huang H, Ran D, Zheng X, Wen L, Zhu Z, et al. HLA-C*01:02 and HLA-A*02:07 confer risk specific for psoriatic patients in Southern China. J Invest Dermatol. 2019;139(9):2045-8.e4.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"603_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/1346-8138.15953","volume":"48","author":"H Terui","year":"2021","unstructured":"Terui H, Yamasaki K, Hagiwara-Takita A, Shimada-Omori R, Tsuchiyama K, Saito-Nanjo Y, et al. Pediatric psoriasis induced by HLA-B46-Cw1 haplotype: a retrospective study of psoriasis onset after hematopoietic stem cell transplantation. J Dermatol. 2021;48(9):1381\u20135.","journal-title":"J Dermatol"},{"issue":"6","key":"603_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/ced.13100","volume":"42","author":"J West","year":"2017","unstructured":"West J, Ogston S, Berg J, Palmer C, Fleming C, Kumar V, et al. HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment. Clin Exp Dermatol. 2017;42(6):651\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"603_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00228-017-2255-x","volume":"73","author":"S Indhumathi","year":"2017","unstructured":"Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS. Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis. Eur J Clin Pharmacol. 2017;73(8):965\u201371.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"603_CR39","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1038\/s41598-018-24491-z","volume":"8","author":"Y Milyausha","year":"2018","unstructured":"Milyausha Y, Rusian V, Fanil B, Zilya S, Leyla S, Bayazit Y. Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein. Sci Rep. 2018;8(1):6098.","journal-title":"Sci Rep"},{"issue":"9","key":"603_CR40","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/jdv.13024","volume":"29","author":"C De Simone","year":"2015","unstructured":"De Simone C, Farina M, Maiorino A, Fanali C, Perino F, Flamini A, et al. TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients. J Eur Acad Dermatol Venereol. 2015;29(9):1786\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"603_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40291-016-0198-z","volume":"20","author":"S Masouri","year":"2016","unstructured":"Masouri S, Stefanaki I, Ntritsos G, Kypreou KP, Drakaki E, Evangelou E, et al. A pharmacogenetic study of psoriasis risk variants in a Greek population and prediction of responses to anti-TNF-alpha and anti-IL-12\/23 agents. Mol Diagn Ther. 2016;20(3):221\u20135.","journal-title":"Mol Diagn Ther"},{"issue":"12","key":"603_CR42","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jamadermatol.2015.2818","volume":"151","author":"A Batalla","year":"2015","unstructured":"Batalla A, Coto E, Coto-Segura P. Influence of Fcgamma receptor polymorphisms on response to anti-tumor necrosis factor treatment in psoriasis. JAMA Dermatol. 2015;151(12):1376\u20138.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"603_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000441719","volume":"232","author":"M Galluzzo","year":"2016","unstructured":"Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, et al. IL12B (p40) gene polymorphisms contribute to ustekinumab response prediction in psoriasis. Dermatology. 2016;232(2):230\u20136.","journal-title":"Dermatology"},{"issue":"3","key":"603_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ds.ds_36_18","volume":"37","author":"TS Chiu","year":"2019","unstructured":"Chiu TS, Tsai TF. Treatment response in patients with moderate to severe psoriasis who had inadequate response to prior secukinumab. Dermatol Sin. 2019;37(3):129\u201333.","journal-title":"Dermatol Sin"},{"issue":"4","key":"603_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/ds.ds_22_19","volume":"37","author":"YW Huang","year":"2019","unstructured":"Huang YW, Tsai TF. Efficacy of tofacitinib in patients with moderate to severe psoriasis who had inadequate responses to prior biologics. Dermatol Sin. 2019;37(4):205\u20138.","journal-title":"Dermatol Sin"},{"issue":"2","key":"603_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ds.ds_51_20","volume":"39","author":"Y Lo","year":"2021","unstructured":"Lo Y, Huang YH, Tsai TF. Long-term efficacy and safety of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed prior secukinumab: a bicentric retrospective study. Dermatol Sin. 2021;39(2):87\u20138.","journal-title":"Dermatol Sin"},{"issue":"1","key":"603_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/bjd.15750","volume":"178","author":"RG Langley","year":"2018","unstructured":"Langley RG, Tsai TF, Flavin S, Song M, Randazzo B, Wasfi Y, et al. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial. Br J Dermatol. 2018;178(1):114\u201323.","journal-title":"Br J Dermatol"},{"key":"603_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.812010","volume":"8","author":"YW Huang","year":"2021","unstructured":"Huang YW, Tsai TF. Exacerbation of psoriasis following COVID-19 vaccination: report from a single center. Front Med (Lausanne). 2021;8: 812010.","journal-title":"Front Med (Lausanne)."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-022-00603-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T05:26:00Z","timestamp":1700803560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-022-00603-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s40291-022-00603-4","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"6 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were received to assist in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Shin-Shin Ho has no conflicts of interest that are directly relevant to the contents of this article. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Galderma, Janssen-Cilag, Merck Sharp & Dohme, Novartis International AG, Pfzer Inc., and UCB Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"This study has been approved by the local Institutional Review Board (20190412RINC, 200712123R).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. The literature search and data analysis were performed by Shin-Shin Ho and Tsen-Fang Tsai. The first draft of the manuscript was written by Shin-Shin Ho and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}